Risk Factors Associated with Recurrent Biliary Obstruction After Endoscopic Bilioduodenal Double Stenting
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-026-10100-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Mitsuru Sugimoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, Fukushima, Jap…. Hauptthemen laut MEDLINE: Stents, Cholestasis. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Endoscopic bilioduodenal double stenting is sometimes necessary for patients with malignant bilioduodenal obstruction (MBDO). The patency of biliary stents is important for preventing cholangitis and continuing treatment. However, the factors that influence recurrent biliary obstruction (RBO) in patients with MBDO are not well known. This study aimed to identify the factors associated with RBO in patients who underwent endoscopic bilioduodenal double stenting. METHODS: Patient characteristics, device use, and endoscopic treatment procedures were evaluated as possible risk factors for RBO. RESULTS: Overall, 55 patients with MBDO underwent endoscopic bilioduodenal double stenting (transpapillary drainage, n = 35; endoscopic ultrasound-guided biliary drainage, n = 20). Multivariate analysis using a Fine and Gray competing risk model revealed that biliary stenting on the oral side of the duodenal stricture (HR 2.98; 95% CI 1.16-7.68; p = 0.023) and chemotherapy (HR 3.74; 95% CI 1.25-11.22; p = 0.018) were significantly associated with RBO. CONCLUSION: Biliary stenting on the oral side of the duodenal stricture was associated with RBO during duodenal stenting in patients with MBDO. Although chemotherapy was also associated with RBO in the multivariable competing risk analysis, this finding should be interpreted cautiously. Careful treatment selection, including consideration of gastrojejunostomy in patients with oral-side biliary stenting, may help reduce the incidence of RBO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, Fukushima, Japan. kita335@fmu.ac.jp.
- Department of Gastroenterology, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, Fukushima, Japan.
- Department of Endoscopy, Fukushima Medical University Hospital, Hikarigaoka 1, Fukushima, Japan.
Zitieren
APA
Sugimoto, M., Takagi, T., Suzuki, R., Asama, H., Shimizu, H., Sato, K., Osawa, K., Ohira, R., Nakamura, J., Kato, T., Yanagita, T., Otsuka, M., Hikichi, T., & Ohira, H. (2026). Risk Factors Associated with Recurrent Biliary Obstruction After Endoscopic Bilioduodenal Double Stenting. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10100-x
Vancouver
Sugimoto M, Takagi T, Suzuki R, Asama H, Shimizu H, Sato K, et al. Risk Factors Associated with Recurrent Biliary Obstruction After Endoscopic Bilioduodenal Double Stenting. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10100-x
BibTeX
@article{Sugimoto2026,
author = {Sugimoto, Mitsuru and Takagi, Tadayuki and Suzuki, Rei and Asama, Hiroyuki and Shimizu, Hiroshi and Sato, Kentaro and Osawa, Kento and Ohira, Rei and Nakamura, Jun and Kato, Tsunetaka and Yanagita, Takumi and Otsuka, Mitsuru and Hikichi, Takuto and Ohira, Hiromasa},
title = {Risk Factors Associated with Recurrent Biliary Obstruction After Endoscopic Bilioduodenal Double Stenting},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10100-x}
}
EUVIMED